ARTICLE | Clinical News
Protalix preclinical data
July 22, 2013 7:00 AM UTC
In mice, oral PRX-106 significantly alleviated immune-mediated hepatitis by reducing interferon (IFN) gamma levels vs. saline controls. Additionally, PRX-106 alleviated immune-mediated colitis by pro...